Interestingly, Cai et al. [104] recently report that Ncapd2 (a murine orthologue to hCAP-D2) is one of 79 DEGs that are differentially expressed in late carcinoma stage (week 12) during murine breast cancer progression. Here, NCAPD2 is linked to breast carcinoma.